✦ LIBER ✦

Tumor Size Does Not Predict Risk of Metastatic Disease or Prognosis of Small Renal Cell Carcinomas

✍ Scribed by Coplen, D.E.

Book ID: 123496619
Publisher: Elsevier Science
Year: 2008
Weight: 47 KB
Volume: 2008
Category: Article
ISSN: 0084-4071
DOI: 10.1016/S0084-4071(08)79035-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tumor Size Does Not Predict Risk of Meta

Tumor Size Does Not Predict Risk of Metastatic Disease or Prognosis of Small Renal Cell Carcinomas

✍ Klatte, Tobias; Patard, Jean-Jacques; de Martino, Michela; Bensalah, Karim; Verh 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 470 KB

Re: Tumor Size Does Not Predict Risk of

Re: Tumor Size Does Not Predict Risk of Metastatic Disease or Prognosis of Small Renal Cell Carcinomas

✍ Mesut Remzi 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Tumor Size Predicts Synchronous Metastat

Tumor Size Predicts Synchronous Metastatic Renal Cell Carcinoma: Implications for Surveillance of Small Renal Masses

✍ Kunkle, David A.; Crispen, Paul L.; Li, Tianyu; Uzzo, Robert G. 📂 Article 📅 2007 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 186 KB

RISK OF METASTATIC RENAL CELL CARCINOMA

RISK OF METASTATIC RENAL CELL CARCINOMA ACCORDING TO TUMOR SIZE

✍ Thompson, R Houston; Hill, Jennifer R; Babayev, Yuriy; Cronin, Angel M; Kaag, Ma 📂 Article 📅 2009 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 92 KB

Metachronous Metastatic Potential of Sma

Metachronous Metastatic Potential of Small Renal Cell Carcinoma: Dependence on Tumor Size

✍ Ja Hyeon Ku; Kyung Chul Moon; Cheol Kwak; Hyeon Hoe Kim 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 153 KB

7121 Bevacizumab (BEV) and interferon (I

7121 Bevacizumab (BEV) and interferon (IFN) therapy does not increase risk of cardiac events in metastatic renal cell carcinoma (mRCC)

✍ Bellmunt, J.; Melichar, B.; Bracarda, S.; Negrier, S.N.; Ravaud, A.; Laeufle, R. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB